Orgenesis Inc. Long-Term Investments Change (Net)

Long-Term Investments Change (Net) of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-Term Investments Change (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Long-Term Investments Change (Net) for the quarter ending September 29, 2021 was $-3 Million (a 27181.82% increase compared to previous quarter)
  • Year-over-year quarterly Long-Term Investments Change (Net) increased by 1216.23%
  • Annual Long-Term Investments Change (Net) for 2019 was $-228 Thousand (a 216.67% increase from previous year)
  • Annual Long-Term Investments Change (Net) for 2018 was $-72 Thousand (a 380.0% increase from previous year)
  • Twelve month Long-Term Investments Change (Net) ending September 29, 2021 was $-3.25 Million (a 584.0% increase compared to previous quarter)
  • Twelve month trailing Long-Term Investments Change (Net) increased by 516.51% year-over-year
Trailing Long-Term Investments Change (Net) for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '19
$-3.25 Million $-475 Thousand $-444 Thousand $-527 Thousand
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-Term Investments Change (Net) of Orgenesis Inc.

Most recent Long-Term Investments Change (Net)of ORGS including historical data for past 10 years.

Interactive Chart of Long-Term Investments Change (Net) of Orgenesis Inc.

Orgenesis Inc. Long-Term Investments Change (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $-3.0 $-0.01 $-0.01
2019 $-0.23 $-0.23 $-0.23
2018 $0.02 $-0.09 $-0.07

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.